Safety and Efficacy Study of KL002 in the Treatment of Advanced Primary PD

NCT05882487 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

GENETIC: KL002 injection solution

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]